Medicis Pharmaceutical Corp Watch

from 8-K 41 pages Medicis Pharmaceutical Corporation 1.375% Convertible Senior Notes Due 2017 Underwriting Agreement May 10, 2012

from SC 13G/A 1 page Exhibit 1 Power of Attorney for Certain Filings Under the Securities Exchange Act of 1934

from SC 13G/A 1 page Exhibit 1 Power of Attorney for Certain Filings Under the Securities Exchange Act of 1934

from SC 13G 1 page Exhibit 1 Power of Attorney for Certain Filings Under the Securities Exchange Act of 1934

from S-4/A ~20 pages Dealer Manager Agreement

from S-3 ~50 pages Underwriting agreement

from S-3/A ~50 pages Form of Underwriting Agreement

from SC 13D/A 1 page Exhibit 1 the Undersigned Hereby Agree That This Amendment to the Schedule 13d Filed by US With Respect to the Class a Common Stock of Medicis Pharmaceutical Corporation Is Filed on Behalf of Each of US. /S/ Phillip Frost, M.D. Date: June 19, 1996 Phillip Frost, M.D. Frost-Nevada, Limited Partnership * Date: June 19, 1996 Neil Flanzraich President of Frost-Nevada Corporation, General Partner Frost-Nevada Corporation * Date: June 19, 1996 Neil Flanzraich President *By /S/ Phillip Frost, M.D. Phillip Frost, M.D